BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+16.77%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$587M
AUM Growth
+$587M
(+19%)
Cap. Flow
+$40.3M
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
69.79%
Holding
31
New
4
Increased
12
Reduced
11
Closed
1
Top Buys
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$41.6M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$15.2M |
| 3 |
CytomX Therapeutics
CTMX
|
$12.7M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$12.5M |
| 5 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$9.25M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$23.3M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$22.5M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$12.7M |
| 4 |
OMED
OncoMed Pharmaceuticals, Inc.
OMED
|
$8.67M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$7.26M |
Sector Composition
| 1 | Healthcare | 65.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
1
DELISTED
Blueprint Medicines
BPMC
| $60M | 10.23% | 2,278,459 +575,805 | +34% | +$15.2M |
|
|
CCXI
2
DELISTED
ChemoCentryx, Inc.
CCXI
| $54.1M | 9.22% | 6,677,722 -895,771 | -12% | -$7.26M |
|
|
CTIC
3
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $53.9M | 9.18% | 43,795,613 +33,795,613 | +338% | +$41.6M |
|
|
CNCE
4
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $42.3M | 7.22% | 2,232,014 -23,154 | -1% | -$439K |
|
|
CASC
5
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $41.7M | 7.11% | 18,799,368 +2,438,830 | +15% | +$5.41M |
|
|
VTAE
6
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $37.3M | 6.36% | 2,061,325 -314,608 | -13% | -$5.69M |
|
|
7
Ironwood Pharmaceuticals
IRWD
$214M
| $34M | 5.8% | 2,935,975 -1,938,398 | -40% | -$22.5M |
|
8
Cytokinetics
CYTK
$4.23B
| $30.6M | 5.21% | 2,920,628 +813,639 | +39% | +$8.51M |
|
|
ARRY
9
DELISTED
Array Biopharma Inc
ARRY
| $28.2M | 4.81% | 6,682,711 -2,997,919 | -31% | -$12.7M |
|
|
FWP
10
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $27.4M | 4.67% | 1,441,287 +424,963 | +42% | +$8.07M |
|
|
OMED
11
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $22.3M | 3.81% | 991,433 -384,680 | -28% | -$8.67M |
|
|
LOXO
12
DELISTED
Loxo Oncology, Inc
LOXO
| $20.2M | 3.45% | 711,067 -820,041 | -54% | -$23.3M |
|
|
ARQL
13
DELISTED
Arqule Inc
ARQL
| $14.8M | 2.52% | 6,809,843 +243,695 | +4% | +$529K |
|
|
QLTI
14
DELISTED
QLT Inc
QLTI
| $14.3M | 2.43% | 5,364,385 +1,626,939 | +44% | +$4.33M |
|
|
15
CytomX Therapeutics
CTMX
$336M
| $12.7M | 2.17% | +608,848 | New | +$12.7M |
|
|
TBRA
16
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $12.6M | 2.15% | 1,253,401 +78,168 | +7% | +$786K |
|
|
FPRX
17
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $12.5M | 2.12% | +300,000 | New | +$12.5M |
|
|
ALPN
18
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $9.25M | 1.58% | +1,195,013 | New | +$9.25M |
|
19
Xenon Pharmaceuticals
XENE
$2.98B
| $9.05M | 1.54% | 1,125,572 +90,000 | +9% | +$724K |
|
|
ONCT
20
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $7.81M | 1.33% | 11,163,136 +390,830 | +4% | +$274K |
|
|
VIRX
21
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.29M | 0.73% | 4,777,381 +2,277,381 | +91% | +$2.04M |
|
22
Cassava Sciences
SAVA
$110M
| $3.24M | 0.55% | 1,852,353 +923,593 | +99% | +$1.62M |
|
23
Gyre Therapeutics
GYRE
$703M
| $3.04M | 0.52% | 970,948 -49,926 | -5% | -$156K |
|
|
GBIM
24
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
| $2.54M | 0.43% | 657,653 -20,747 | -3% | -$80.1K |
|
25
Savara
SVRA
$567M
| $1.55M | 0.26% | 3,696,961 -1,407,107 | -28% | -$591K |
|